• 中文核心期刊要目总览
  • 中国科技核心期刊
  • 中国科学引文数据库(CSCD)
  • 中国科技论文与引文数据库(CSTPCD)
  • 中国学术期刊文摘数据库(CSAD)
  • 中国学术期刊(网络版)(CNKI)
  • 中文科技期刊数据库
  • 万方数据知识服务平台
  • 中国超星期刊域出版平台
  • 国家科技学术期刊开放平台
  • 荷兰文摘与引文数据库(SCOPUS)
  • 日本科学技术振兴机构数据库(JST)
ZHANG Jia-Rui, OUYANG Xuan, HOU Chi, YANG Qi-Feng, Wu Yingjun, LU Wen-Ju, LIU Chun-Li, YANG Kai, ZHONG Nan-Shan, WANG Jian, CHEN Yu-Qin. Natural ingredients from Chinese materia medica for pulmonary hypertension [J].Chin J Nat Med, 2021, 19(11): 801-814. doi: 10.1016/S1875-5364(21)60092-4
Citation: ZHANG Jia-Rui, OUYANG Xuan, HOU Chi, YANG Qi-Feng, Wu Yingjun, LU Wen-Ju, LIU Chun-Li, YANG Kai, ZHONG Nan-Shan, WANG Jian, CHEN Yu-Qin. Natural ingredients from Chinese materia medica for pulmonary hypertension [J].Chin J Nat Med, 2021, 19(11): 801-814. doi: 10.1016/S1875-5364(21)60092-4

Natural ingredients from Chinese materia medica for pulmonary hypertension

  • Abstract: Pulmonary hypertension (PH) is a severe pathophysiological condition characterized by pulmonary artery remodeling and continuous increases in pulmonary artery pressure, which may eventually develop to right heart failure and death. Although newly discovered and incredible treatment strategies in recent years have improved the prognosis of PH, limited types of effective and economical drugs for PH still makes it as a life-threatening disease. Some drugs from Chinese materia medica (CMM) have been traditionally applied in the treatment of lung diseases. Accumulating evidence suggests active pharmaceutical ingredients (APIs) derived from those medicines brings promising future for the prevention and treatment of PH. In this review, we summarized the pharmacological effects of APIs derived from CMM which are potent in treating PH, so as to provide new thoughts for initial drug discovery and identification of potential therapeutic strategies in alternative medicine for PH.

     

/

返回文章
返回